American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
Bruce E. Hillner(American Society of Clinical Oncology), David G. Pfister(Memorial Sloan Kettering Cancer Center), Kathy S. Albain(Loyola University Chicago), James N. Ingle(Mayo Clinic), Gary C. Yee(American Society of Clinical Oncology), J. Sybil Biermann(American Society of Clinical Oncology), Nora A. Janjan(The University of Texas MD Anderson Cancer Center), Rowan T. Chlebowski(The Ohio State University), Allan Lipton(National Cancer Centre Japan), James R. Berenson(Oncotherapeutics (United States))
Cited by 383
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k